Anticorps humains anti-alpha-synucléine

[1]  P. Chan,et al.  Semi-quantitative analysis of α-synuclein in subcellular pools of rat brain neurons: An immunogold electron microscopic study using a C-terminal specific monoclonal antibody , 2008, Brain Research.

[2]  R. Dodel,et al.  Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders. , 2008, Autoimmunity reviews.

[3]  E. Waxman,et al.  Characterization of antibodies that selectively detect α-synuclein in pathological inclusions , 2008, Acta Neuropathologica.

[4]  Sandra Lynch,et al.  An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity. , 2008, Journal of molecular biology.

[5]  M. Sierks,et al.  Isolation of a human single chain antibody fragment against oligomeric α-synuclein that inhibits aggregation and prevents α-synuclein induced toxicity , 2007 .

[6]  Sanetaka Shirahata,et al.  Recent advances in the generation of human monoclonal antibody , 2007, Cytotechnology.

[7]  Michael L. Kramer,et al.  Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies , 2007, The Journal of Neuroscience.

[8]  V. Buchman,et al.  Autoantibodies to alpha‐synuclein in inherited Parkinson’s disease , 2006, Journal of neurochemistry.

[9]  David W. Miller,et al.  α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication , 2004, Neurology.

[10]  Bin Yuan,et al.  Inhibiting Aggregation of α-Synuclein with Human Single Chain Antibody Fragments† , 2004 .

[11]  Matthew P Frosch,et al.  The Formation of Highly Soluble Oligomers of α-Synuclein Is Regulated by Fatty Acids and Enhanced in Parkinson's Disease , 2003, Neuron.

[12]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[13]  J. Trojanowski,et al.  A panel of epitope‐specific antibodies detects protein domains distributed throughout human α‐synuclein in lewy bodies of Parkinson's disease , 2000, Journal of neuroscience research.

[14]  J. Trojanowski,et al.  Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein , 1999, Neuroscience Letters.

[15]  J. Trojanowski,et al.  Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease , 1999, Annals of neurology.

[16]  N. Dracopoli,et al.  Current protocols in human genetics , 1994 .

[17]  P. Thorpe,et al.  The Preparation and Cytotoxic Properties of Antibody‐Toxin Conjugates , 1982, Immunological reviews.

[18]  F Wold,et al.  Posttranslational covalent modification of proteins. , 1977, Science.

[19]  Edith Mathiowitz,et al.  Encyclopedia of Controlled Drug Delivery , 1999 .

[20]  Alfonso R. Gennaro,et al.  Remington:the science and practice of pharmacy , 1995 .

[21]  E. Coligan.  Current protocols in immunology , 1991 .

[22]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[23]  K. Struhl,et al.  Current Protocols in Molecular Biology (New York: Greene Publishing Associates and Wiley-Interscience). Host-Range Shuttle System for Gene Insertion into the Chromosomes of Gram-negative Bacteria. , 1988 .

[24]  J. Walker.  The Enzyme Linked Immunosorbent Assay (ELISA) , 1987 .

[25]  S. Sell,et al.  Monoclonal antibodies and cancer therapy , 1985 .

[26]  R. W. Baldwin,et al.  Monoclonal antibodies for cancer detection and therapy , 1985 .

[27]  J. Goding.  Monoclonal antibodies: Principles and practice : production and application of monoclonal antibodies in cell biology, biochemistry, and immunology , 1983 .